GPRC5A Is a Potential Oncogene in Pancreatic Ductal Adenocarcinoma Cells That Is Upregulated by Gemcitabine With Help From HuR

Cell Death and Disease - United Kingdom
doi 10.1038/cddis.2016.169
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Interstitial Pressure in Pancreatic Ductal Adenocarcinoma Is Dominated by a Gel-Fluid Phase

Biophysical Journal
Biophysics
2016English

Increased Expression of Plakoglobin Is Associated With Upregulated MAPK and PI3K/AKT Signalling Pathways in Early Resectable Pancreatic Ductal Adenocarcinoma

Oncology Letters
Cancer ResearchOncology
2020English

HMGA1 Is a Molecular Determinant of Chemoresistance to Gemcitabine in Pancreatic Adenocarcinoma

Clinical Cancer Research
Cancer ResearchOncology
2008English

GPRC5A: A Potential Tumor Suppressor and Oncogene

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2009English

Increased CDC20 Expression Is Associated With Pancreatic Ductal Adenocarcinoma Differentiation and Progression

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2012English

Elevated McP-1 Is Associated With Cancer Cachexia in Patients With Pancreatic Ductal Adenocarcinoma

HPB
HepatologyGastroenterology
2017English

ST6Gal-I Sialyltransferase Promotes Chemoresistance in Pancreatic Ductal Adenocarcinoma by Abrogating Gemcitabine-Mediated DNA Damage

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2017English

P8 Is a New Target of Gemcitabine in Pancreatic Cancer Cells

Clinical Cancer Research
Cancer ResearchOncology
2006English

CCAT2 Is an Oncogenic Long Non-Coding RNA in Pancreatic Ductal Adenocarcinoma

Biological Research
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgricultural
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy